IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH

IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH

SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 8, 2025 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel cell...

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions

Advancing Strategic Advisory Capabilities for Corporate Clients NEW YORK, Dec. 5, 2025 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or "the Company"), a leading commercial real estate advisor and service provider to large...

Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics

Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics

Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets and China Collaboration designed to accelerate and expand the development of synergistic...

UNESCO and Walnut Coding join forces to advance digital education

UNESCO and Walnut Coding join forces to advance digital education

Partnership aims to bridge the digital divide and equip youth with future-ready skills BEIJING, Dec. 4, 2025 /PRNewswire/ -- UNESCO has signed a partnership agreement with Walnut Coding, a leading digital education platform for young learners, to...

Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem

Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem

Hyundai Motor Group and Air Liquide reaffirm leadership in the hydrogen sector as co-chairs of the Hydrogen Council, driving global hydrogen ecosystem expansion Partnership focuses on building a sustainable energy ecosystem across Europe, U.S. and...

Nona Biosciences Appoints Dr. Hongjiang Miao as Chief AI Officer to Advance A³ Strategy and AI-Driven Drug Discovery

Nona Biosciences Appoints Dr. Hongjiang Miao as Chief AI Officer to Advance A³ Strategy and AI-Driven Drug Discovery

CAMBRIDGE, Mass., Dec. 4, 2025 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea to IND), today announced the...

MediaGo Secures Consecutive Honors in the Global Tech Awards AdTech Category

MediaGo Secures Consecutive Honors in the Global Tech Awards AdTech Category

SAN FRANCISCO, Dec. 2, 2025 /PRNewswire/ -- In the recently announced results of the 2025 Global Tech Awards, MediaGo — an intelligent advertising platform — once again secured top honors in the AdTech Excellence category with its newly upgraded...

Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy

Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy

SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...

Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials

Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials

Securely connecting AI agents across multiple companies for rapid response to changing circumstances KAWASAKI, Japan, Dec. 1, 2025 /PRNewswire/ -- Fujitsu Limited today announced the development of a multi-AI agent collaboration technology that...

Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours

Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours

Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytics (CF33-CD19) oncolytic virus and JW's CD19 CAR-T cell therapy, Carteyva®, in refractory solid...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 23
  • menu
    menu